Newsroom

Sorted by: Latest

-

David Walch, Former King Street Co-Portfolio Manager, Joins Harraden Circle

NEW YORK--(BUSINESS WIRE)--Harraden Circle Investments, LLC (“Harraden”), a New York-based, research-driven investment firm, today announced the appointment of David Walch as Portfolio Manager, effective November 1, 2026. Walch joins Harraden after 14 years at King Street Capital Management, where he was most recently Partner and Co-Portfolio Manager. At Harraden, Walch will work alongside Founder and Chief Investment Officer Fritz Fortmiller to develop and co-manage a new opportunistic strateg...
-

Balyasny Asset Management LP UK Regulatory Announcement: Form 8.3 DCC plc

LONDON--(BUSINESS WIRE)--  FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, the tr...
-

Advyzon Announces 2027 Advyzon Conference: Showcasing the Next Wave of AI-Powered Wealth Management Innovation

CHICAGO--(BUSINESS WIRE)--Advyzon, a global AI-powered, unified wealth management technology and data platform, today announced details for the fourth annual 2027 Advyzon Conference, taking place February 24–26, 2027 at the Fairmont Dallas. Registration is now open, with early bird rates available through October. Bringing together financial advisors, investment managers, technology innovators, and industry professionals, the three-day event will offer an inside look at Advyzon’s latest product...
-

Pagaya Reports Third Quarter 2026 Results

NEW YORK & TEL AVIV, Israel--(BUSINESS WIRE)--Pagaya Technologies Ltd. (NASDAQ: PGY) (“Pagaya”, the “Company” or “we”), a global technology company delivering AI-driven product solutions for the financial ecosystem, today announced financial results for the third quarter 2026. For additional information, view Pagaya’s third quarter 2026 letter to shareholders here. “Our momentum is building on itself: more partners, more products, and more applications feeding a network that is becoming essenti...
-

Mintegral Earns Top Global Rankings Across Gaming, Non-Gaming and Creative in AppsFlyer's 2026 Performance Index

SINGAPORE--(BUSINESS WIRE)--Mintegral today announced strong results in the AppsFlyer Performance Index 2026 Edition....
-

Precision BioSciences to Report Third Quarter 2026 Financial Results on November 3, 2026

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced that it will publish financial results for the third quarter 2026 and provide a business update on Tuesday, November 3, 2026.About Precision BioSciences, Inc.Precision BioSciences, Inc. is a clinical stage gene editing company dedicated to improving l...
-

PureTech Founded Entity Celea Therapeutics Appoints Paul Audhya, MD, MBA, as Chief Medical Officer

BOSTON--(BUSINESS WIRE)--PureTech Founded Entity Celea Therapeutics Appoints Paul Audhya, MD, MBA, as Chief Medical Officer...
-

STAAR Surgical Appoints Pascal Aeschlimann as Vice President of Asia Pacific

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced the appointment of Pascal Aeschlimann as Vice President of Asia Pacific, effective November 2, 2026. Mr. Aeschlimann, who led STAAR’s commercial expansion across Asia and the Middle East from 2002 to 2010, returns after more than a decade building and leading...
-

Entegris Reports Results for Third Quarter of 2026

BILLERICA, Mass.--(BUSINESS WIRE)--Entegris, Inc. (NASDAQ: ENTG), today reported its financial results for the Company’s third quarter ended September 26, 2026. Dave Reeder, Entegris’ President and Chief Executive Officer, said: “Entegris is executing well against an attractive long-term opportunity, driven by increasing semiconductor complexity, rising materials intensity, and investment in leading-edge technologies. Our ability to deliver the performance, quality, and reliability our customer...
-

Cosm Medical Achieves Reimbursement Pathway Milestone: US CPT® Codes Recognize the Work Behind Personalized Pessaries

TORONTO--(BUSINESS WIRE)--Cosm Medical co-led revision of CPT® Category III codes 0559T/0560T, letting US providers report the work of personalizing Gynethotics™ pessaries....